Ablation of kidney tumors

Area of Science:

• Urology
• Minimally Invasive Surgery
• Oncology

Background:

• Surgical excision is the primary curative treatment for small renal cell carcinomas (RCC).
• Ablative therapies provide a minimally invasive, kidney-sparing alternative for patients unsuitable for surgery.
• Laparoscopic cryoablation and percutaneous radiofrequency ablation (RFA) are established, with increasing use of percutaneous cryoablation and laparoscopic RFA.

Purpose of the Study:

• To evaluate the role of ablative therapy in treating small renal cell carcinomas.
• To compare the outcomes of ablative therapies with traditional surgical methods.
• To highlight the importance of patient selection for ablative procedures.

Main Methods:

• Review of current literature on renal cell carcinoma treatment modalities.
• Analysis of outcomes for laparoscopic cryoablation, percutaneous RFA, percutaneous cryoablation, and laparoscopic RFA.
• Comparison of renal function preservation, complication rates, and oncologic outcomes.

Main Results:

• Ablative therapies demonstrate favorable renal function and complication profiles.
• Oncologic outcomes following ablative therapy are generally less effective than surgical excision.
• Increasing frequency of percutaneous cryoablation and laparoscopic RFA observed.

Conclusions:

• Ablative therapy is a viable kidney-sparing option for select patients with small renal cell carcinomas who are poor surgical candidates.
• Careful patient selection is crucial due to the current limitations in oncologic outcomes compared to surgery.
• Further research may focus on improving oncologic efficacy of ablative techniques.